Zepp Health Q1 Adjusted Loss Per ADS $(0.19) Misses $(0.03) Estimate, Sales $39.80M Miss $46.24M Estimate
Portfolio Pulse from Benzinga Newsdesk
Zepp Health (NYSE:ZEPP) reported a Q1 adjusted loss of $(0.19) per ADS, significantly missing the analyst estimate of $(0.03). Sales also fell short at $39.80 million against the expected $46.24 million, marking a 57.64% year-over-year decline.
May 20, 2024 | 9:04 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Zepp Health reported a Q1 adjusted loss of $(0.19) per ADS, missing the $(0.03) estimate by a wide margin. Sales also fell short at $39.80 million, missing the $46.24 million estimate and showing a significant year-over-year decline.
The significant miss on both earnings and sales estimates, coupled with a substantial year-over-year decline in sales, is likely to negatively impact Zepp Health's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100